Quarterly report pursuant to Section 13 or 15(d)

Shareholders' Deficit (Tables)

v3.24.2.u1
Shareholders' Deficit (Tables)
6 Months Ended
Jun. 30, 2024
Shareholders' Deficit (Tables) [Line Items]  
Schedule of Stock Option Activities During the six months ended June 30, 2024 and 2023, Series B preferred stock activity is as follows:
    For the Six Months Ended
June 30, 2024
    For the Six Months Ended
June 30, 2023
 
    Number of
Shares
    Amount     Number of
Shares
    Amount  
Balance at beginning of period     1,144     $ 1,203,967       1,000     $ 1,037,201  
Shares issued for accrued compensation     312       312,000       144       144,000  
Shares issued for compensation     50       50,000      
-
     
-
 
Shares and accrued dividends forfeited     (317 )     (334,009 )    
-
     
-
 
Dividends accrued    
-
      13,355      
-
      11,226  
Balance at end of period     1,189     $ 1,245,313       1,144     $ 1,192,427  

 

During the six months ended June 30, 2024 and 2023, Series C preferred stock activity is as follows:
    For the Six Months Ended
June 30, 2024
    For the Six Months Ended
June 30, 2023
 
    Number of Shares     Amount     Number of Shares     Amount  
Balance at beginning of period     15,150     $ 1,621,160       17,290     $ 1,803,731  
Conversion of Series C shares to common shares     (600 )     (60,000 )     (1,840 )     (184,000 )
Dividends accrued    
-
      14,743      
-
      16,079  
Balance at end of period     14,550     $ 1,575,903       15,450     $ 1,635,810  
Schedule of Activity Related to Non-Vested Shares The following table summarizes activity related to non-vested shares:
    Number of
Non-Vested
Shares
    Weighted
Average
Grant Date
Fair Value
 
Non-vested, December 31, 2023     14,970,120     $ 0.132  
Shares vested    
-
     
-
 
Non-vested, June 30, 2024     14,970,120     $ 0.132  
Warrant [Member]  
Shareholders' Deficit (Tables) [Line Items]  
Schedule of Stock Option Activities Warrant activities for the six months ended June 30, 2024 are summarized as follows:
    Number of
Warrants
    Weighted
Average
Exercise
Price
    Weighted
Average
Remaining
Contractual
Term (Years)
    Aggregate
Intrinsic
Value
 
Balance Outstanding December 31, 2023     34,000,000     $ 0.011       2.73     $
      -
 
Expired     (600,000 )    
-
     
-
     
-
 
Balance Outstanding June 30, 2024     33,400,000     $ 0.01       2.28     $
-
 
Exercisable, June 30, 2024     33,400,000     $ 0.01       2.28     $
-
 

 

Stock Options [Member]  
Shareholders' Deficit (Tables) [Line Items]  
Schedule of Stock Option Activities Stock option activities for the six months ended June 30, 2024 are summarized as follows:
    Number of
Options
    Weighted
Average
Exercise
Price
    Weighted
Average
Remaining
Contractual
Term (Years)
    Aggregate
Intrinsic
Value
 
Balance Outstanding, December 31, 2023     8,445,698     $ 0.40       2.43      
       -
 
Expired     (1,100,000 )    
-
     
-
     
-
 
Balance Outstanding, June 30, 2024     7,345,698     $ 0.44       2.25     $
-
 
Exercisable, June 30, 2024     7,345,698     $ 0.44       2.25     $
-